| Literature DB >> 21078207 |
Mariana Boadella1, Tania Carta, Alvaro Oleaga, Gerardo Pajares, Marta Muñoz, Christian Gortázar.
Abstract
BACKGROUND: The roe deer is the most abundant and widespread wild Eurasian cervid. Its populations are expanding and increasingly in contact with livestock. This may affect the distribution of infectious diseases shared with other wild and domestic ungulates.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21078207 PMCID: PMC2994849 DOI: 10.1186/1746-6148-6-51
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Figure 1In circles, the eight defined sampling populations with the number of sampled animals in each. A, Coruña; B, Occidental Cantabrian Coast; C, Oriental Cantabrian Coast; D, Cantabrian mountains; E, Iberian mountains; F, Central mountains; G, Toledo mountains; H, Alcornocales.
Serologic tests employed for serological assay of roe deer sera sampled
| Agent (group) | Test | Antigen | Conjugate | Reference |
|---|---|---|---|---|
| BVDv/BDv (Pestivirus) | ELISA; SERELISA® BVD/BD p80 Ab. Mono Blocking, Synbiotics; Lyon, France. | protein p80/125 | None (blocking test) | [ |
| ELISA; SERELISA® BVD/BD p80 Ag. Mono Indirect, Synbiotics; Lyon, France. | None | Goat Ab anti-rabbit Ig/peroxidase | [ | |
| IBRv (Herpesvirus) | ELISA; SERELISA® IBR/IPV Ab. Mono Indirect Synbiotics; Lyon, France. | glycoprotein gB | MAb anti-bovine IgG/peroxidase | [ |
| Bluetongue virus | Ingezim BTV Compac 2.0 12.BTV.K3®, Ingenasa; Madrid, Spain. | recombinant VP7 | None (blocking test) | [ |
| ELISA; In-house modified including positive controls. | PPA-3 | Protein-G/peroxidase | [ | |
| Rose Bengal agglutination test | Rose Bengal | None | [ |
Serologic prevalence of selected infectious diseases in roe deer sampled, according to the eight sampling populations
| Population | Sera analyzed | Pestivirus | Herpesvirus | BTV | MAP | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sera* | Prevalence (%) | Sera* | Prevalence (%) | Sera* | Prevalence (%) | Sera* | Prevalence (%) | Sera* | Prevalence (%) | ||
| 95% CI | 95% CI | 95% CI | 95% CI | 95% CI | |||||||
| A | 61 | 0/61 | 0 | 0/61 | 0 | 0/21 | 0 | 10/61 | 16.4 | 0/42 | 0 |
| (0-4.87) | (0-4.87) | (0-15.8) | (8.74-27.74) | (0-8.92) | |||||||
| B | 79 | 1/79 | 1.3 | 0/79 | 0 | 0/27 | 0 | 8/79 | 10.1 | 0/37 | 0 |
| (0.07-6.75) | (0-4.75) | (0-12.38) | (4.76-18.84) | (0-9.05) | |||||||
| C | 120 | 2/120 | 1.7 | 0/120 | 0 | 0/16 | 0 | 6/120 | 5 | 0/30 | 0 |
| (0.03-6.06) | (0-3.13) | (0-20.83) | (2.2-10.69) | (0-11.15) | |||||||
| D | 113 | 2/113 | 1.8 | 0/113 | 0 | 0/42 | 0 | 11/113 | 9.7 | 0/26 | 0 |
| (0.03-6.44) | (0-3.32) | (0-8.92) | (5.16-16.7) | (0-12.85) | |||||||
| E | 15 | 0/15 | 0 | 1/15 | 6.7 | 0/14 | 0 | 2/15 | 13.3 | 0/10 | 0 |
| (0-22.22) | (0.35-30.2) | (0-23.81) | (2.43-39.67) | (0-29.08) | |||||||
| F | 74 | 3/74 | 4.1 | 0/71 | 0 | 0/41 | 0 | 7/74 | 9.46 | 0/19 | 0 |
| (1.12-11.29) | (0-4.79) | (0-8.17) | (4.53-18.72) | (0-17.65) | |||||||
| G | 8 | 0/8 | 0 | 0/8 | 0 | 0/1 | 0 | 0/8 | 0 | 0/7 | 0 |
| (0-37.71) | (0-36.46) | (0-94.99) | (0-36.46) | (0-37.71) | |||||||
| H | 49 | 0/49 | 0 | 0/49 | 0 | 0/10 | 0 | 4/49 | 8.2 | 0/30 | 0 |
| (0-7.65) | (0-7.65) | (0-29.08) | (2.84-19.18) | (0-11.15) | |||||||
| Total | 519 | 8/519 | 1.5 | 1/516 | 0.2 | 0/172 | 0 | 48/519 | 9.2 | 0/201 | 0 |
| (0.05-3.04) | (0-1.1) | (0-2.18) | (7.01-12.11) | (0-1.87) | |||||||
*positive sera/tested sera
Figure 2Antibody prevalences found in 10 recent serosurveys of Spanish roe deer (2007-2010). Squares (■,□) indicate viruses, diamonds (♦,◊) are for bacterial diseases and triangles (▲) for parasites. White backgrounds indicate vector-borne diseases. References for Pestivirus, [14,15]; BTv, [17]; Neospora, [36,37]; Coxiella burnetii, [27]; C. abortus, [28], Toxoplasma, [31,36]; and Anaplasma, [29].